spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Aesthetic Medicine 

 HSMN NewsFeed - 14 Sep 2020
CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)
Devices Regenerative Medicine Wound Care Distribution
 HSMN NewsFeed - 11 Jun 2020
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
Devices Dermatology Product Launch
 HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
Devices Dermatology Venture Capital
 HSMN NewsFeed - 10 Feb 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 29 May 2019
LifeSprout, Inc. Closes $6.5 Million Seed Series Financing, Appoints Industry Veteran Adam Gridley as Executive Chairman
Devices Dermatology Venture Capital Personnel
 HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Devices Oncology Dermatology Personnel
 HSMN NewsFeed - 25 Oct 2017
Cellect Announces a Major Breakthrough of its ApoGraft(TM) Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center
Regenerative Medicine
 HSMN NewsFeed - 27 Mar 2017
Syneron Candela Announces CE Mark for CO2RE(R) Intima
Devices Regulatory
 HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2014
Syneron Receives US FDA Clearance to Market the UltraShape System for Fat Cell Destruction
Devices Dermatology FDA
 HSMN NewsFeed - 11 Feb 2014
Lithera Announces Final Closing of $35.6 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Nov 2013
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 18 Jul 2013
Lithera Announces Second Closing of $27.3 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jun 2013
Mentor Announces Launch of CPX(TM)4 Tissue Expander in EMEA
Devices Product Launch
 HSMN NewsFeed - 17 Sep 2012
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 May 2012
KYTHERA Biopharmaceuticals Announces Presentation of Positive Results from First of Two ATX-101 European Phase III Trials for Reduction of Submental Fat
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Devices Acquisitions
 HSMN NewsFeed - 2 Apr 2012
Solta Medical Introduces Liposonix(R) at AMWC in Monaco and Announces its Portfolio of Aesthetic Energy Devices Reaches Industry Milestone With More Than 2 Million Procedures Completed Globally
Devices
 HSMN NewsFeed - 19 Mar 2012
Merz Pharmaceuticals Introduces New Mederma(R) Advanced Scar Gel
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Mar 2012
The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Mar 2012
KYTHERA Biopharmaceuticals Appoints Industry Veteran Elisabeth Sandoval as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2011
KYTHERA Biopharmaceuticals Announces $37.4M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2011
Solta Medical Transitions Leadership Team
Devices Personnel
 HSMN NewsFeed - 8 Feb 2011
Ulthera Announces $10.5 Million in Series C Venture Capital Funding
Devices Venture Capital
 HSMN NewsFeed - 10 Jan 2011
KYTHERA and Intendis Announce Initiation of European Phase III Clinical Development Program to Evaluate ATX-101 for Reduction of Submental Fat
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Jul 2010
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
Devices FDA
 HSMN NewsFeed - 27 Apr 2010
KYTHERA Biopharmaceuticals Appoints Industry Veteran as Vice President, Global Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2010
Merz Aesthetics Announces FDA Approval of Asclera(TM) (Polidocanol) Injection, First Sclerosant to Treat Small Varicose Veins in 60 Years
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2010
Merz to Complete Acquisition of BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2010
Ethicon Completes Acquisition of Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2010
Merz to Acquire BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 11 Aug 2009
ETHICON Introduces New Product Enhancement and Packaging for BIOPATCH(R) to Improve Ease of Application for Patients with Catheters
Devices Wound Care
 HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 30 Apr 2009
FDA Approves Dysport(TM) for Therapeutic and Aesthetic Uses
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Apr 2009
BioSante Announces Launch of Elestrin in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 18 Feb 2009
KYTHERA BIOPHARMACEUTICALS Secures Additional $10M
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 23 Jan 2009
Johnson & Johnson Completes Acquisition of Mentor Corporation
Devices Mergers & Acquisitions
 HSMN NewsFeed - 7 Aug 2008
BioSante Pharmaceuticals Announces Reacquisition of Elestrin(TM), FDA Approved for Treatment of Hot Flashes
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Jul 2008
Palomar Medical Expands Its Product Portfolio Through a Distribution Agreement with Astron Clinica
Devices Dermatology Distribution
 HSMN NewsFeed - 9 Jun 2008
Senetek PLC Announces Key Personnel Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Kythera Biopharmaceuticals Announces $40M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 May 2008
Revance Announces Series C Expansion
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2008
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2008
Syneron Announces R&D Management Transition
Devices Personnel
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 4 Dec 2007
Reliant Technologies Receives Industry's Only FDA 510(K) Clearance for a Fractional Ablative Resurfacing Device
Devices Dermatology FDA
 HSMN NewsFeed - 29 Nov 2007
Kythera Biopharmaceuticals Appoints Amgen Veteran as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
BioSante Pharmaceuticals Announces FDA Clarity on Development of LibiGel(R) (Transdermal Testosterone Gel) in the Treatment of Female Sexual Dysfunction
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Sep 2007
Plastic and Reconstructive Surgery Publishes Clinical Trial Results of Ultrashape(TM) Non-Invasive Body Contouring System
Devices
 HSMN NewsFeed - 5 Sep 2007
UltraShape Secures $15.1 Million in New Financing Led by Meritech Capital
Devices Venture Capital
 HSMN NewsFeed - 5 Sep 2007
BioSante Pharmaceuticals Names Joy A. Thomas Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jul 2007
Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 May 2007
Syneron Announces Management Change in Support of Company's Long-Term Growth Strategies
Devices Personnel
 HSMN NewsFeed - 14 May 2007
UltraShape(TM) Introduces Second Generation CONTOUR I at EADV Annual Meeting
Devices Dermatology
 HSMN NewsFeed - 30 Apr 2007
Alma Lasers(TM) Receives FDA Clearance for the Accent(TM) Dual Mode RF System
Devices FDA
 HSMN NewsFeed - 27 Apr 2007
Kythera Biopharmaceuticals Appoints New Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
Mentor Appoints Edward S. Northup as Vice President, Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 4 Oct 2006
Aqueduct Medical to Launch the AqueCool(TM) Rapid Recovery System(TM) for Enhanced Healing after Cosmetic Surgery at Plastic Surgery Annual Meeting
Devices
 HSMN NewsFeed - 27 Jun 2006
Mentor Appoints Joseph A. Newcomb as Vice President, Secretary and General Counsel
Devices Personnel
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
Aesthetic Medicine
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.